Molecular Epidemiology of Invasive Group B <i>Streptococcus</i> in South Africa, 2019–2020
In our setting, β-lactam antibiotics remain appropriate for GBS treatment and polysaccharide and protein-based vaccines under development are expected to provide good coverage.
Authors
- Scott Hazelhurst (ORCID: https://orcid.org/0000-0002-0581-149X)
- Linda de Gouveia (ORCID: https://orcid.org/0000-0002-1418-8468)
- Susan Meiring (ORCID: https://orcid.org/0000-0003-4508-5469)
- Lesley McGee (ORCID: https://orcid.org/0000-0001-8214-921X)
- Vanessa Quan (ORCID: https://orcid.org/0000-0003-1666-4752)
- Kedibone Ndlangisa (ORCID: https://orcid.org/0000-0001-6441-2539)
- Senzo Mtshali (ORCID: https://orcid.org/0000-0002-2210-894X)
- Arshad Ismail (ORCID: https://orcid.org/0000-0003-4672-5915)
- Nicole Wolter (ORCID: https://orcid.org/0000-0002-9526-0133)
- Benjamin J. Metcalf (ORCID: https://orcid.org/0000-0002-9628-2051)
- Anne von Gottberg (ORCID: https://orcid.org/0000-0002-0243-7455)
- Mignon du Plessis (ORCID: https://orcid.org/0000-0001-9186-0679)
- Sopio Chochua (ORCID: https://orcid.org/0000-0001-8222-7353)
- Buhle Ntozini (ORCID: https://orcid.org/0009-0002-9951-4433)
- Dineo Mogale
Institutions
- National Health Laboratory Service (ZA)
- Centers for Disease Control and Prevention (US)
- Durban University of Technology (ZA)
- National Center for Immunization and Respiratory Diseases (US)
- University of the Witwatersrand (ZA)
- University of Venda (ZA)
Publication Details
- Journal
- The Journal of Infectious Diseases
- Published
- 2024-12-31
- DOI
- https://doi.org/10.1093/infdis/jiae633
- Citations
- 5
- Primary Topic
- Neonatal and Maternal Infections
- Type
- article
- Field-Weighted Citation Impact
- 2.71
Funders
- Centers for Disease Control and Prevention